The recent official ban of cannabidiol in foods, supplements, and any other products in Hong Kong has been attributed to the difficulty in controlling tetrahydrocannabinol – the psychoactive component in cannabis.
The ratio of cannabidiol (CBD) to tetrahydrocannabinol (THC) in medicinal cannabis has shown to play a crucial role in improving the physical and functional wellbeing of brain cancer patients, according to newly published findings in a trial funded by...
A number of Thai companies, including CP Foods and DOD Biotech, have stated their intentions in developing new food, supplement and beverages containing hemp, as new regulatory developments unfold in the country.
Supplements containing cannabidiol (CBD) should be made available in health foods stores in Australia, trade body Complementary Medicines Australia (CMA) has said as the country’s regulator reviews existing rules.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.